UA87513C2 - Фармацевтическая композиция, содержащая дроспиренон и этинилэстрадиол - Google Patents

Фармацевтическая композиция, содержащая дроспиренон и этинилэстрадиол

Info

Publication number
UA87513C2
UA87513C2 UAA200702482A UAA200702482A UA87513C2 UA 87513 C2 UA87513 C2 UA 87513C2 UA A200702482 A UAA200702482 A UA A200702482A UA A200702482 A UAA200702482 A UA A200702482A UA 87513 C2 UA87513 C2 UA 87513C2
Authority
UA
Ukraine
Prior art keywords
ethynylestradiol
drospirenone
pharmaceutical composition
formulation
comprises drospirenone
Prior art date
Application number
UAA200702482A
Other languages
English (en)
Ukrainian (uk)
Inventor
Карлос Арьель Сандроне
Хосе Марио Саксон
Басайстеги Мария дель Кармен Кахарвилье
Поми Хосе Даниель Ларроса
Original Assignee
Лабораториос Ликонса, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929434&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA87513(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Лабораториос Ликонса, С.А. filed Critical Лабораториос Ликонса, С.А.
Publication of UA87513C2 publication Critical patent/UA87513C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Изобретение относится к фармацевтической композиции, которая содержит дроспиренон и этинилэстрадиол в аморфной форме, адсорбированные на терапевтически инертной твердой основе, в сочетании с фармацевтически приемлемыми наполнителями, причем она содержит летучий растворитель метиленхлорид. Изобретение также относится к способу получения такой композиции.
UAA200702482A 2004-08-09 2005-08-02 Фармацевтическая композиция, содержащая дроспиренон и этинилэстрадиол UA87513C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04103837A EP1625849A1 (en) 2004-08-09 2004-08-09 Pharmaceutical composition comprising drospirenone and ethynylestradiol

Publications (1)

Publication Number Publication Date
UA87513C2 true UA87513C2 (ru) 2009-07-27

Family

ID=34929434

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200702482A UA87513C2 (ru) 2004-08-09 2005-08-02 Фармацевтическая композиция, содержащая дроспиренон и этинилэстрадиол

Country Status (19)

Country Link
US (1) US20090227546A1 (ru)
EP (2) EP1625849A1 (ru)
JP (1) JP2008509195A (ru)
KR (1) KR20070045247A (ru)
CN (1) CN101022811B (ru)
AR (1) AR045576A1 (ru)
AT (1) ATE464053T1 (ru)
AU (1) AU2005271206B2 (ru)
BR (1) BRPI0513938B8 (ru)
CA (1) CA2574997A1 (ru)
DE (1) DE602005020694D1 (ru)
ES (1) ES2344356T3 (ru)
IL (1) IL180899A0 (ru)
MA (1) MA28844B1 (ru)
NO (1) NO20071297L (ru)
RU (1) RU2007108666A (ru)
UA (1) UA87513C2 (ru)
WO (1) WO2006015956A1 (ru)
ZA (1) ZA200702038B (ru)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2531929T3 (es) * 2006-12-20 2015-03-20 Teva Women's Health, Inc. Formas de dosificación solidas que se disgregan en la boca que comprenden progestina y métodos para hacer y usar las mismas
HUP0700826A3 (en) 2007-12-20 2010-03-29 Richter Gedeon Nyrt Coated tablet containing drospirenone and process for producing the same
DE102008037025C5 (de) 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
KR102023255B1 (ko) 2009-04-01 2019-09-19 바이알 - 포르텔라 앤드 씨에이 에스에이 니트로카테콜 유도체를 포함하는 제약 제제 및 그의 제조 방법
JP5864410B2 (ja) * 2009-04-01 2016-02-17 ノヴィファーマ ソシエテ アノニム ニトロカテコール誘導体を含む医薬製剤及びその製造方法
US10849857B2 (en) * 2010-07-28 2020-12-01 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US11351122B1 (en) 2010-07-28 2022-06-07 Laboratorios Leon Farma Sa Synthetic progestogens and pharmaceutical compositions comprising the same
AR081670A1 (es) 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
US9603860B2 (en) * 2010-07-28 2017-03-28 Laboratorios Leon Farma Sa Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same
US20140045900A1 (en) 2011-02-11 2014-02-13 Bial-Portela & Ca, S.A. Administration regime for nitrocatechols
CN102274235B (zh) * 2011-06-27 2013-03-13 潍坊中狮制药有限公司 一种新的避孕药物组合及制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727064A (en) * 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
FR2722984B1 (fr) * 1994-07-26 1996-10-18 Effik Lab Procede de preparation de formes pharmaceutiques seches et les compositions pharmaceutiques ainsi realisees
US6027747A (en) * 1997-11-11 2000-02-22 Terracol; Didier Process for the production of dry pharmaceutical forms and the thus obtained pharmaceutical compositions
EP1598069B1 (en) * 1999-08-31 2009-04-22 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
EE05317B1 (et) * 1999-08-31 2010-08-16 Bayer Schering Pharma Aktiengesellschaft Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
DK1361881T3 (da) * 2000-12-14 2006-02-20 Ortho Mcneil Pharm Inc Steroide hormonprodukter og fremgangsmåder til fremstilling heraf
EP1216712A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Cyclodextrin-drospirenone inclusion complexes

Also Published As

Publication number Publication date
ATE464053T1 (de) 2010-04-15
AU2005271206B2 (en) 2009-11-26
KR20070045247A (ko) 2007-05-02
RU2007108666A (ru) 2008-09-20
DE602005020694D1 (de) 2010-05-27
EP1625849A1 (en) 2006-02-15
BRPI0513938B1 (pt) 2018-09-25
BRPI0513938B8 (pt) 2021-05-25
CN101022811A (zh) 2007-08-22
EP1848441A1 (en) 2007-10-31
JP2008509195A (ja) 2008-03-27
ES2344356T3 (es) 2010-08-25
ZA200702038B (en) 2008-08-27
NO20071297L (no) 2007-05-02
BRPI0513938A (pt) 2008-05-20
CN101022811B (zh) 2010-09-15
AU2005271206A1 (en) 2006-02-16
AR045576A1 (es) 2005-11-02
EP1848441B1 (en) 2010-04-14
HK1109579A1 (en) 2008-06-13
WO2006015956A1 (en) 2006-02-16
MA28844B1 (fr) 2007-09-03
US20090227546A1 (en) 2009-09-10
CA2574997A1 (en) 2006-02-16
IL180899A0 (en) 2007-07-04

Similar Documents

Publication Publication Date Title
NO20070887L (no) Kornformet farmasoytisk preparat med tidsbegrenset frigivelse for oral administrasjon, og intraoral hurtig desintegrerende tablett som inneholder preparatet
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
MX2009001711A (es) Formulaciones de liberacion sostenida de topiramato.
TW200612987A (en) Combination treatment for non-hematologic malignancies
UA89615C2 (ru) Фармацевтические композиции, которые содержат никотиновую кислоту и антагонист рецептора dp
WO2008011596A3 (en) Hydrophilic abuse deterrent delivery system
MX2010010954A (es) Farmaco contra cancer de higado.
MX2009004616A (es) Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente.
SG166093A1 (en) Inhibitors of brutonæs tyrosine kinase
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
IL158559A (en) Use of 5-lipoxygenase inhibitors for the preparation of a pharmaceutical composition for treating acne
MY173215A (en) Acetylcysteine compositions and methods of use thereof
WO2006039704A3 (en) Pharmaceutical composition and method for treating a joint capsule arthropathy
TW200640497A (en) Pharmaceutical formulations and methods of use
ZA200810124B (en) Pharmaceutical combination comprising 3-(3-dimethyl-amino-1-ethyl-2-methyl-propyl)-phenol and Paracetamol
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
NZ718163A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
TW200603787A (en) Topical preparations containing ambroxol
IL180900A0 (en) Immunogenic complexes, preparation method thereof and use of same in pharmaceutical compositions
JP2009522376A5 (ru)
WO2008075320A3 (en) Antilipidemic pharmaceutical compositions and process for preparation thereof
WO2007018588A8 (en) Stable pharmaceutical composition comprising linezolid form iv
NO20091628L (no) Kombinasjonsmedikament
GEP20125636B (en) Slow-release formulation based on glycogen and alginate association
BRPI0513938A (pt) composição farmacêutica contendo drospirenona e etinilestradiol